Skip to main content
  • English
  • Français
  • About Us
    • About Us
    • Our Purpose and Identity
    • Integrated Report 2021
    • Governance
      • Governance
      • Board of Directors
      • Executive Committee
    • Where we are
    • Through time
    • All Our Stories
      • All Our Stories
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
  • Your Health
    • Your Health
    • Health and Well-Being
    • Diabetes and Cardiovascular Diseases
    • Specialty Care
      • Specialty Care
      • Rare Diseases
      • Rare Blood Disorders
      • Neurology
      • Immunology
      • Oncology
        • Oncology
        • When Cancer Grows Old
          • When Cancer Grows Old
          • Contributions Initiative
          • Global collaboration
      • Patient Support
    • Vaccines
      • Vaccines
      • The Value of vaccines
      • How immunization works
      • Infection Disease and Vaccine
        • Infection Disease and Vaccine
        • COVID-19
        • Influenza
        • Meningococcal Meningitis
        • Pertussis
        • Poliomyelitis
        • Respiratory Syncytial Virus
        • Discover more
      • Research and Innovation
      • Vaccines Production
      • Vaccines Stories
  • Science & Innovation
    • Science & Innovation
    • Partnering
      • Partnering
      • Let's partner
      • Areas of Interest
        • Areas of Interest
        • China & Emerging Markets
        • Digital
        • General Medicines
        • Immunology
        • Neuroscience
        • Oncology
        • Out-Licensing
        • Rare Diseases
        • Technology Platforms
        • Vaccines
      • Meet the team
    • Research & Development
      • Research & Development
      • Sanofi Pipeline
      • Vaccines
      • Immunology and Inflammation
      • Neurology
      • Oncology
      • Pioneering Technology Platforms
        • Pioneering Technology Platforms
        • Genomic Medicine Technology Platform
        • mRNA Technology: Vaccines and Beyond
        • NANOBODY® Technology Platform
        • SYNTHORIN™ Technology Platform
      • Rare Blood Disorders R&D
      • Rare Diseases
      • Voices from the Lab
    • Clinical Trials & Results
      • Clinical Trials & Results
      • Phases
      • Our disclosure commitments
        • Our disclosure commitments
        • Sanofi Pharma
        • Sanofi Genzyme
        • Sanofi Pasteur
      • Our data sharing commitments
      • Managed Access Programs (MAPs)
      • Investigator Sponsored Studies and Externally Sponsored Collaboration
    • Collaboration & Awards
      • Collaboration & Awards
      • Europe
        • Europe
        • iAwards
        • iDEA-iTECH
      • North America
        • North America
        • iAwards
        • iDEA-iTECH
    • Science Stories
  • Our Responsibility
    • Our Responsibility
    • Access to Quality Healthcare – Sanofi Global Health
    • Environmental sustainability
    • Diversity, Equity and Inclusion
      • Diversity, Equity and Inclusion
      • Making an Impact
      • Board & Employee Groups
      • Gender Balance
        • Gender Balance
        • Women@Sanofi
      • Our Partners
      • Our LGBTQ+ Voice
    • Healthcare for all
      • Healthcare for all
      • Sanofi Humanitarian Aid Programs
      • Contributing to the eradication, elimination and control of some infectious diseases
      • Fighting Against Falsified Medicine
      • Serving the needs of patients with non-communicable diseases
    • Corporate Citizenship
    • Foundation S (Endowment Fund)
    • Ethics & Transparency
      • Ethics & Transparency
      • Code of Ethics
    • Suppliers
    • Document center
      • Document center
      • All factsheets
      • Access to Healthcare and Pricing
      • Country reports and other documents
      • CSR Strategy and Value Creation
      • Environment
      • Duty of Vigilance incl. Supply Chain
      • Ethics & Transparency
      • Governance, Controls and Procedures
      • Reporting Frameworks and Indicators
      • Social incl. Communities
  • |
  • Careers
    • Careers
    • Explore our career opportunities
    • A range of possibilities
      • A range of possibilities
      • Market access
      • Marketing
      • Medical
      • Production
      • Research & Development
      • Consumer Healthcare
      • Vaccines careers
      • Student / Graduate / Young Professionals
      • Discover more possibilities
    • Grow with us
      • Grow with us
      • Diversity & Inclusion
      • Development opportunity: how Sanofi empowers you
      • Benefits
  • Investors
    • Investors
    • Company overview
      • Company overview
      • Sanofi at a glance
      • Strategy
      • Financial reporting center & Key data
      • Fixed income
    • Financial results and events
      • Financial results and events
      • Financial calendar
      • Quarterly earnings at a glance
      • Investor presentations
      • Annual General Meetings
      • Broker conferences
    • Sanofi share and ADRs
      • Sanofi share and ADRs
      • Share overview
        • Share overview
        • Shares & voting rights
        • Share repurchases
      • Sanofi stock chart
      • Shareholding calculator
      • Dividends
      • ADRs
      • Shareholding structure
      • Vara consensus
    • Corporate governance
      • Corporate governance
      • Governance
      • Board of Directors
      • Executive Committee
      • Specialist committees
      • Compensations
      • Standards & rules
      • Regulated agreements
      • Internal Control
    • Individual Shareholders
      • Individual Shareholders
      • Welcome to Sanofi
      • Being a shareholder
        • Being a shareholder
        • Five reasons to be a Sanofi shareholder
        • How to buy Sanofi shares
        • Registered shares
      • Shareholder events
        • Shareholder events
        • Financial Calendar
        • Annual General Meetings
        • Participate in General Meetings
      • Reports and publications
        • Reports and publications
        • Financial and CSR reports
        • Shareholder publications
      • Shareholders committee
    • Reports and publications
      • Reports and publications
      • Financial and CSR reports
      • Shareholder publications
    • Regulated information
    • Contacts
  • Media
    • Media
    • Press releases
      • Press releases
      • 2022
        • 2022
        • Press Release: Sanofi and Innovent Biologics enter strategic collaboration to accelerate development of oncology medicines and expand presence in China
      • 2021
      • 2020
      • 2019
      • 2018
    • Articles
      • Articles
      • 2019
    • Contacts
    • Media Alert
Worldwide
EN
  • EN
  • FR

OUR RESPONSIBILITY

Ethics & Transparency

  • Home
  • Our responsibility
  • Document center
  • Ethics & Transparency
BACK TO THE MAIN PAGE
  • Apr 2, 2021 • FACTSHEET
    Animal Protection
  • Nov 1, 2017 • POLICY, CODE & CHARTER
    Anti-Bribery Policy
  • Jan 1, 2017 • FACTSHEET
    Binding Corporate Rules & List of Sanofi Affiliates Having Signed the BCR
  • Jun 1, 2022 • FACTSHEET
    Biodiversity
  • Jun 1, 2019 • POLICY, CODE & CHARTER
    Bioethics : Clinical Trial Data Sharing Policy
  • Jun 1, 2019 • POLICY, CODE & CHARTER
    Bioethics : Collection Storage and Use of Human Biological Samples for Research Policy
  • Jun 1, 2019 • POLICY, CODE & CHARTER
    Bioethics : Compassionate Use Policy
  • Jun 1, 2019 • POLICY, CODE & CHARTER
    Bioethics : Gene Therapy and Genome Editing Policy
  • Jun 1, 2019 • POLICY, CODE & CHARTER
    Bioethics : Human Embryonic Stem Cells Policy
  • Jun 1, 2019 • POLICY, CODE & CHARTER
    Bioethics : Incidental Findings Policy
  • Jul 29, 2022 • POLICY, CODE & CHARTER
    Bioethics : Post Trial Access to Investigational Products Policy
  • Jun 1, 2019 • POLICY, CODE & CHARTER
    Bioethics : Research Using Human Fetal Tissue Policy
  • Sep 5, 2020 • POLICY, CODE & CHARTER
    Bioethics : Sanofi's Policy Position on Minority Diversity in Human Clinical Trials
  • Mar 1, 2019 • POLICY, CODE & CHARTER
    Board Charter
  • Apr 1, 2019 • POLICY, CODE & CHARTER
    Code of Ethics
  • Jun 1, 2022 • FACTSHEET
    Corporate Governance
  • Mar 4, 2022 • BROCHURE
    Declaration of Extra-Financial Performance
  • May 1, 2022 • FACTSHEET
    Emerging Risk Management
  • May 1, 2022 • FACTSHEET
    Ethics & Business Integrity
  • May 1, 2022 • FACTSHEET
    Fight Against Falsified Medicines and Illict Trafficking
  • Jun 1, 2022 • FACTSHEET
    Fighting Malaria
  • Mar 17, 2022 • POLICY, CODE & CHARTER
    Global Quality Policy
  • Jun 16, 2021 • FACTSHEET
    Guiding principles of AI at Sanofi
  • May 1, 2022 • FACTSHEET
    Internal Audit
  • May 1, 2022 • FACTSHEET
    Internal Control and Processes
  • May 1, 2022 • FACTSHEET
    Lobbying
  • May 1, 2022 • FACTSHEET
    Medical Ethics & Bioethics and Clinical Trials
  • May 1, 2022 • FACTSHEET
    Pharmacovigilance
  • Jun 1, 2022 • FACTSHEET
    Promotional Practices
  • May 1, 2022 • FACTSHEET
    Protection of Personal Data
  • May 1, 2022 • FACTSHEET
    Quality Management System
  • May 1, 2022 • FACTSHEET
    Risk Management
  • Oct 10, 2018 • POLICY, CODE & CHARTER
    Sanofi Policy on the Protection of Animals
  • Oct 5, 2018 • POLICY, CODE & CHARTER
    Sanofi Policy on the Protection of Animals (DE)
  • May 1, 2022 • FACTSHEET
    Serialization: Medicine Identification, Authentification & Traceability
  • Apr 23, 2020 • FACTSHEET
    Service Engagements with Scientific Experts
  • May 1, 2022 • FACTSHEET
    Tax Policy
Sanofi

    Follow us

  • Contact
  • Legal notice
  • Privacy & Data Protection
  • Cookies policy
  • Corporate code of ethics
  • Our publications
  • Sitemap
  • Our websites
  • Accessibility: partial compliance

© Sanofi 2004-2022 - All rights reserved

You are about to leave sanofi.com

If you wish to continue to this external website, click Proceed.

It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.

PROCEED